Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback